FDA moves to fast-track three psychedelic drugs for review
Source: NBC News Politics · Bias: Center Left
Summary
A day after the DOJ said it would ease restrictions on medical marijuana, the FDA moves to fast-track some experimental psychedelic drugs for review. They're looking at three drugs for treatment-resistant depression, major depressive disorder, and PTSD. NBC's Anne Thompson reports.
Related Coverage
- Review: Gore Vidal's Burr Is the Anti-Hamilton (Center Right — Reason.com)
- What to Know About the Heat Dome, in Three Charts (Center — WSJ.com : U.S. News)
- Three lessons from this year’s primaries: From the Politics Desk (Center Left — NBC News Politics)
- US moves to eliminate long-time radiation safety principle for nuclear power (Center — The Hill News)
- Conservative National Review slams MAGA for 'abuse of' Amy Coney Barrett (Left — Alternet.org)
- Trump: Gas prices not falling fast enough (Center — The Hill News)
- ‘Not what I voted for’: Three-time Trump voter tears president apart (Left — Alternet.org)
- Three alternative July 4 fireworks shows if you want to skip the National Mall (Center Right — Washington Examiner)
Daily Analysis
Read the full Parallax Pulse for April 24, 2026 — an AI-powered analysis of how Left and Right media covered the biggest stories this day.
More Headlines From April 24, 2026
- Bolton lambasts US-Iran peace talks: ‘Nowhere close to a deal’ (Center)
- Justice Department Calls for Expansion of Federal Death Penalty (Center)
- DOJ Drops Fed Probe, Clearing Way for Warsh | Balance of Power: Early Edition 4/24/2026 (Center)
- After 2 failed votes, Mike Johnson unveils new plan to extend key U.S. spy powers (Center)
- Trump Talks Up Iran Blockade as Israel-Lebanon Truce Extended (Center)






